Actinium Pharmaceuticals
ATNM
ATNM
48 hedge funds and large institutions have $15.6M invested in Actinium Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
2.81% less ownership
Funds ownership: 17.56% → 14.75% (-2.8%)
32% less capital invested
Capital invested by funds: $23.1M → $15.6M (-$7.48M)
Holders
48
Holding in Top 10
–
Calls
$3.16M
Puts
$2.7M
Top Buyers
| 1 | +$1.85M | |
| 2 | +$501K | |
| 3 | +$429K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$423K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$255K |
Top Sellers
| 1 | -$5.5M | |
| 2 | -$1.83M | |
| 3 | -$1.64M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$276K |
| 5 |
Morgan Stanley
New York
|
-$241K |